Degradation of Mcl-1 by β-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization
Degradation of Mcl-1 by β-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization
复制标题
DOI:
10.1128/mcb.00620-06
复制
发表时间:
2007-06-01
影响因子:
5.3
通讯作者:
Hung, Mien-Chie
中科院分区:
文献类型:
--
作者:
Ding, Qingqing;He, Xianghuo;Hung, Mien-Chie
Apoptosis is critical for embryonic development, tissue homeostasis, and tumorigenesis and is determined largely by the Bcl-2 family of antiapoptotic and prosurvival regulators. Here, we report that glycogen synthase kinase 3 (GSK-3) was required for Mcl-1 degradation, and we identified a novel mechanism for proteasome-mediated Mcl-1 turnover in which GSK-3 beta associates with and phosphorylates Mcl-1 at one consensus motif ((155)STDG(159)SLPS(163)T; phosphorylation sites are in italics), which will lead to the association of Mcl-1 with the E3 ligase beta-TrCP, and beta-TrCP then facilitates the ubiquitination and degradation of phosphorylated Mcl-1. A variant of Mcl-1 (Mcl-1-3A), which abolishes the phosphorylations by GSK-3 beta and then cannot be ubiquitinated by beta-TrCP, is much more stable than wild-type Mcl-1 and able to block the proapoptotic function of GSK-3 beta and enhance chemoresistance. Our results indicate that the turnover of Mcl-1 by P-TrCP is an essential mechanism for GSK-3 beta-induced apoptosis and contributes to GSK-3 beta-mediated tumor suppression and chemosensitization.